Status:

COMPLETED

Optimization of Contrast Agent Dose in CT With Lean Body Weight

Lead Sponsor:

IRCCS Policlinico S. Donato

Conditions:

Contrast Agent With Lean Body Weight

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This study evaluates the different enhancement using a contrast agent dose in computed tomography based on total body weight or based on lean body weight. Half of participants will receive contrast ag...

Detailed Description

Patients will undergo a CT scan of abdomen (multi-phasic) with contrast agent and will be measured: total body weight (TBW), height, lean body weight (LBW) and body mass index (BMI) through formulas k...

Eligibility Criteria

Inclusion

  • Patient ≥ 18 years of age;
  • Patients who will perform a contrast-enhanced abdominal CT multi-phasic in our institutions;
  • Patients able to give informed consent.

Exclusion

  • history of chronic underlying liver disease (cirrhosis, fatty infiltration of the liver, or glycogen storage disease);
  • history of chronic underlying heart disease (congestive heart failure, prior cardiac valve replacement, restrictive and/or constrictive pericarditis);
  • multiple myeloma;
  • hypersensitivity to iodine-containing compounds;
  • renal insufficiency (serum creatinine level ≤ 1.8 mg/dL \[159.12 µmol/L\]) or patients with renal failure (eGR \<30 ml/min/1.73 m2);
  • patients with antecubital vein that, at medical evaluation, cannot sustain the flow rate of CA injection (see below);
  • patients carrier of prosthesis or metal bullets, pacemaker or stimulators;
  • patients with liver diseases that affect the entire parenchyma;
  • fragile patients which, after radiologist evaluation, require lower dose of CA;
  • pregnancy;
  • general contraindications to CT examination or reasoned decision of the radiologist.

Key Trial Info

Start Date :

December 18 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 25 2019

Estimated Enrollment :

274 Patients enrolled

Trial Details

Trial ID

NCT03384979

Start Date

December 18 2017

End Date

February 25 2019

Last Update

May 6 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS Policlinico San Donato

San Donato Milanese, Milan, Italy, 20097